Clinical Trials on Glycogen Storage Disease Type III in Norway
Total 1161 results
-
Chiesi Farmaceutici S.p.A.Active, not recruitingFabry DiseaseBelgium, United States, United Kingdom, Italy, Czechia, Denmark, Norway
-
Rigshospitalet, DenmarkNordic Society for Pediatric Hematology and OncologyCompletedAcute Lymphoblastic LeukemiaFinland, Denmark, Norway, Sweden, Iceland
-
Kancera ABNordic Society of Gynaecological Oncology - Clinical Trials UnitRecruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerDenmark, Norway, Sweden
-
Clavis PharmaSyneos Health; TheradexCompletedAcute Myeloid LeukemiaUnited States, Norway, Germany, France
-
Clavis PharmaCompletedMalignant MelanomaUnited States, Sweden, Norway
-
Rigshospitalet, DenmarkNordic Society for Pediatric Hematology and OncologyCompletedAcute Lymphoblastic LeukemiaFinland, Denmark, Iceland, Norway, Sweden
-
Nordic Myeloma Study GroupJanssen-Cilag Ltd.Unknown
-
Royal Devon and Exeter NHS Foundation TrustNational Institute for Health Research, United Kingdom; University of ExeterCompletedType2 DiabetesUnited Kingdom
-
Regeneron PharmaceuticalsSanofiCompletedHeterozygous Familial HypercholesterolemiaUnited Kingdom, Netherlands, Czech Republic, Norway
-
University of Central ArkansasCompletedDiabetes Mellitus, Type 2United States
-
Amsterdam UMC, location VUmcRoche Pharma AG; Baxter Healthcare Corporation; UMC Utrecht; Fresenius Medical... and other collaboratorsCompletedCardiovascular Disease | End-stage Renal DiseaseNetherlands, Norway, Canada
-
Karolinska InstitutetMedical University of Vienna; Oslo University Hospital; Sahlgrenska University... and other collaboratorsTerminatedAcute Myeloid LeukemiaCanada, Austria, Sweden, Russian Federation, Norway
-
Genzyme, a Sanofi CompanyTerminatedFabry DiseaseAustria, Brazil, France, United States, Argentina, Belgium, Canada, Finland, Hungary, Norway, Poland, Spain, Taiwan, United Kingdom
-
Marjukka KolehmainenLund University; Uppsala University; Aarhus University Hospital; University of... and other collaboratorsCompletedCardiovascular Diseases | Insulin Resistance | Type 2 Diabetes | Impaired Glucose Tolerance | Abdominal ObesitySweden, Denmark, Finland, Iceland, Norway
-
University of AarhusNordic Lymphoma GroupCompletedPeripheral T-Cell LymphomaNorway, Finland, Denmark
-
Jørgen Bjerggaard JensenNovo Nordisk A/S; University of AarhusRecruitingNon-muscle Invasive Bladder CancerDenmark, Norway, Latvia
-
MendusAmsterdam UMC, location VUmcActive, not recruitingAcute Myeloid Leukemia in RemissionNorway, Netherlands, Sweden, Finland, Germany
-
Åslaug HellandBristol-Myers Squibb; Oslo University Hospital; Ultimovacs ASAActive, not recruitingCancer | Mesothelioma | Mesotheliomas Pleural | Cancer of Lung | Cancer, Lung | Mesothelioma; Pleura | Mesothelioma; LungNorway, Denmark, Sweden, Spain, Australia
-
Nordic Society of Gynaecological Oncology - Clinical...WithdrawnOvarian CancerNorway, Denmark, Finland
-
Oslo University HospitalUniversity Hospital of North Norway; Helse Stavanger HF; Haukeland University... and other collaboratorsRecruiting
-
Ida Bruun KristensenOdense Patient Data Explorative Network; Karyopharm Therapeutics IncActive, not recruitingMultiple MyelomaDenmark, Norway, Estonia
-
Hospices Civils de LyonRecruitingPeritoneal Malignant MesotheliomaBelgium, Portugal, France, Germany, India, Norway
-
European Myeloma NetworkSanofi; Amgen; EMN Research ItalyActive, not recruitingMultiple MyelomaCzechia, Germany, Greece, Italy, Netherlands, Norway, Spain
-
Grupo Español de Investigación en Cáncer de OvarioHoffmann-La Roche; Apices Soluciones S.L.; AGO Study Group; ARCAGY/ GINECO GROUP; Multicenter Italian Trials in Ovarian cancer and gynecologic malignancies and other collaboratorsActive, not recruitingCarcinoma of the Cervix, Stage IVBNorway, Spain, France, Sweden, United States, Germany, Italy, Japan
-
Jeanette LundinRecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaSweden, Norway
-
Commissariat A L'energie AtomiqueAssistance Publique - Hôpitaux de ParisUnknownHepatocellular CarcinomaFrance
-
Active Biotech ABCompletedRenal Cell Carcinoma | Pancreatic Cancer | Non-Small-Cell Lung CarcinomaUnited States, Norway, United Kingdom
-
Forest LaboratoriesPhenomixTerminatedDiabetes Mellitus, Type IIUnited States, Belarus, India, Romania, Germany, Lithuania
-
ShireCompletedHunter Syndrome | Mucopolysaccharidosis II (MPS II)United States, France, United Kingdom, Germany, Sweden, Spain, Brazil, Canada, Italy, Romania
-
AstraZenecaActive, not recruitingStage IB-IIIA Non-small Cell Lung CarcinomaUnited States, Italy, Netherlands, Belgium, Canada, Poland, Romania, Taiwan, Thailand, Vietnam, France, Brazil, Hungary, Japan, Russian Federation, Turkey, China, Korea, Republic of, Germany, Hong Kong, Spain, Australia, Israel, Ukraine, Swed...
-
Yale UniversityNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingDiabetes Mellitus, Type 2 | Patient EducationUnited States
-
University of CambridgeJuvenile Diabetes Research Foundation; The Leona M. and Harry B. Helmsley Charitable... and other collaboratorsUnknownType 1 Diabetes MellitusAustria, Italy, Finland, Denmark, Germany, Belgium, United Kingdom, France, Luxembourg, Norway, Poland, Slovenia, Sweden
-
Norwegian University of Science and TechnologyCompletedLeukemia, Myeloid, Chronic-PhaseSweden, Finland, Norway
-
Nordic Society of Gynaecological Oncology - Clinical...European Network of Gynaecological Oncological Trial Groups (ENGOT); Gynecologic...Completed
-
Idorsia Pharmaceuticals Ltd.Active, not recruitingFabry DiseaseUnited States, United Kingdom, Norway, Germany, Australia, Canada, Spain, Switzerland, Austria, Belgium, France, Netherlands, Poland
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedFamilial HypercholesterolemiaUnited States, Spain, Turkey, Canada, Belgium, Germany, Greece, Hungary, Italy, Norway, Poland, Puerto Rico, Russian Federation, Slovakia, Switzerland
-
Lund University HospitalMundipharma Pte Ltd.; Roche Pharma AG; CelgeneCompletedMantle Cell LymphomaFinland, Denmark, Norway, Sweden
-
ProtalixChiesi Farmaceutici S.p.A.CompletedFabry DiseaseUnited States, Netherlands, Hungary, United Kingdom, Czechia, Norway, Slovenia, Spain, Finland, France, Italy, Switzerland
-
University of OxfordNational Institute for Health Research, United Kingdom; European Commission; Oxford... and other collaboratorsTerminatedOsteosarcomaUnited Kingdom, Germany, Italy, Netherlands, Norway
-
Novartis PharmaceuticalsTerminatedUveal MelanomaUnited States, Australia, France, Netherlands, Spain, Norway
-
Karolinska University HospitalThe Swedish Research Council; University of LeipzigRecruitingEsophageal Squamous Cell CarcinomaCanada, Sweden, Norway, Ireland
-
Eli Lilly and CompanyAlkermes, Inc.CompletedDiabetes Mellitus, Type 2United States, Argentina, Portugal, South Africa
-
AmgenCompletedHyperlipidemiaCanada, France, Netherlands, United Kingdom, New Zealand, South Africa, Spain, United States, Australia, Germany, Sweden, Hong Kong, Switzerland, Norway
-
Galderma R&DCompletedWarts | Actinic Keratosis | Basal Cell Carcinoma | Squamous Cell Carcinoma | Bowens DiseaseDenmark, Germany, Norway, Sweden, United Kingdom
-
The Netherlands Cancer InstituteUnknownMyxoid Liposarcoma of Soft TissueNetherlands, United Kingdom, Norway, United States, Denmark
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesNorway, United Kingdom, Sweden, Finland
-
Nordic Myeloma Study GroupNordic Cancer UnionCompletedMultiple MyelomaDenmark, Norway, Sweden
-
Idorsia Pharmaceuticals Ltd.CompletedFabry DiseaseUnited States, Spain, Belgium, Australia, Austria, Canada, Germany, Ireland, Italy, Netherlands, Norway, Poland, Switzerland, United Kingdom
-
Genentech, Inc.RecruitingMultiple MyelomaSpain, Australia, Denmark, Norway